You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 118 No. 11, November 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ampicillin-Sulbactam vs Clindamycin in Head and Neck Oncologic Surgery

The Need for Gram-negative Coverage

Randal S. Weber, MD; Issam Raad, MD; Robert Frankenthaler, MD; Patti Hankins, RN; Robert M. Byers, MD; Oscar Guillamondegui, MD; Pat Wolf; Terry Smith, MS; Helmuth Goepfert, MD

Arch Otolaryngol Head Neck Surg. 1992;118(11):1159-1163.


Abstract

• This study was undertaken to assess whether gram-negative antimicrobial coverage is required in patients undergoing head and neck oncologic surgery. Ampicillin sodium–sulbactam sodium and clindamycin phosphate were compared in a prospective, randomized, parallel, double-blind trial of 212 patients undergoing head and neck procedures involving clean-contaminated wounds. Both antibiotics were given up to 1 hour before surgery and continued at 6-hour intervals after surgery for an additional eight doses. Fourteen infections occurred in the ampicillin-sulbactam–treated group (13.3%) and 29 infections in the clindamycin-treated group (27.1%). From patients receiving clindamycin, 29 gram-negative organisms were isolated, compared with six from those patients receiving ampicillin-sulbactam. This finding supports the need for gram-negative coverage in patients undergoing clean-contaminated head and neck oncologic surgery.

(Arch Otolaryngol Head Neck Surg. 1992;118:1159-1163)



Author Affiliations

From the Department of Head and Neck Surgery (Drs Weber, Frankenthaler, Byers, Guillamondegui, and Goepfert and Mss Hankins and Wolf), Department of Medical Specialties, Section of Infectious Diseases (Dr Raad), and Department of Biomathematics (Ms Smith), University of Texas M. D. Anderson Cancer Center, Houston.


Footnotes

Accepted for publication May 6, 1992.

Reprint requests to Department of Head and Neck Surgery, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 (Dr Weber).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Brain Abscess Formation: A Delayed Complication of Carotid Blowout Syndrome Treated by Self-Expandable Stent-Graft
Chang et al.
Am. J. Neuroradiol. 2006;27:1543-1545.
ABSTRACT | FULL TEXT  

Three-Dose vs Extended-Course Clindamycin Prophylaxis for Free-Flap Reconstruction of the Head and Neck
Carroll et al.
Arch Otolaryngol Head Neck Surg 2003;129:771-774.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.